ArticleInternational journal of preventive medicine2026
Hepato-renal Protective Effect of Glutamine in Oxidative Stress Rat Model by Elevating the Glutamine-Glutathione Axis.
Article in International journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Toxic compounds such as carbon tetra chloride (CCl4) can cause acute hepato-renal injury by producing free radicals and inflammatory mediators. Therefore, we examined the impact of glutamine (Gln) on oxidative stress and inflammatory markers in blood and tissue homogenates, as well as hepato-renal dysfunction markers and histopathological parameters in an oxidative stress rat model induced by CCl Methods: The study included four groups, each comprising nine rats: control (C), oxidative stress rat model (OSRM), and those treated with Gln (1,000 mg/L in drinking water for 2 weeks). Oxidative stress was induced by administering CCl Results: The findings indicated that Gln treatment significantly reduced liver and kidney histopathological changes caused by oxidative stress induction. The treatment lowered hepatic NF-kβ expression, liver and renal dysfunction parameters, and markers of oxidative stress and inflammation. Moreover, it notably improved systemic, renal, and hepatic antioxidant potential ( Conclusions: The hepato-renoprotective effects of Gln included the prevention of liver necrosis and renal tubule disturbance. Gln enhanced liver and kidney functions by reducing NF-kβ signaling and boosting systemic, hepatic, and renal antioxidant potential through elevating the glutathione (GSH)/GSSG ratio and antioxidant enzyme activities. It is likely that the enhancement of the glutamine-glutathione axis is the primary mechanism behind its hepato-renoprotective effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.